PreciPoint builds hardware and software to digitize microscopy and laboratory processes, offering fully motorized transmitted-light microscopes (M8, O8, FRITZ) and the PreciCloud virtual microscopy platform. Its product portfolio includes the iO:M8 ROSE solution for digitizing intraoperative cancer-surgery assessments and software tools to visualize and analyze images. The company is pursuing technologies for Label‑Free Diagnostics and high‑speed product solutions to reduce sample pre-treatment and accelerate workflows. PreciPoint is ISO 13485 certified and has positioned products for customers in medicine, research, and education. Based in Freising, Germany, the company has won awards such as Top100 Innovator and Top Startup Employer in healthcare. The business plans emphasize international commercialization and a U.S. market entry supported by recent financing.

Total raised

$10M

Funding rounds

1

Latest round

Series A

Latest activity

Jul 2022